Platelet-Membrane-Encapsulated Carvedilol with Improved Targeting Ability for Relieving Myocardial Ischemia–Reperfusion Injury

In recent years, cell membrane drug delivery systems have received increasing attention. However, drug-loaded membrane delivery systems targeting therapy in myocardial ischemia–reperfusion injury (MIRI) have been relatively rarely studied. The purpose of this study was to explore the protective effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Tingting, Yang, Xuechao, Wang, Tianyi, Xu, Mingming, Huang, Zhanghao, Yu, Runze, Jiang, Yi, Zhou, Youlang, Shi, Jiahai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227294/
https://www.ncbi.nlm.nih.gov/pubmed/35736311
http://dx.doi.org/10.3390/membranes12060605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227294/
https://www.ncbi.nlm.nih.gov/pubmed/35736311
http://dx.doi.org/10.3390/membranes12060605

Ejemplares similares